The need is substantial: the World Health Organization reported in 2025 that more than one billion people live with mental-health conditions. WHO's mental-health-at-work fact sheet estimates 12 billion working days lost each year to depression and anxiety, with roughly US$1 trillion in annual productivity loss. These are global public-health and economic estimates, not niomi.ai market share, revenues or product outcomes. The opportunity is to serve unmet continuity needs responsibly—from everyday resilience to clinician-linked follow-up—without treating every person as a patient.
A viable route to market would start with a narrow, defined use case and an accountable operating owner. Consumer, clinic, employer and payer models each require different permissions, privacy protections, evidence standards and service commitments. Clinical pathways should advance only after validated safety controls, human-response capacity and jurisdiction-specific approvals. Responsible scale is a sequence of earned permissions, not a single launch date.
